Is pharmaceutical expenditure related to the business cycles?

被引:0
|
作者
Blazquez-Fernandez, Carla [1 ]
Cantarero-Prieto, David [1 ]
Pascual-Saez, Marta [1 ]
机构
[1] Univ Cantabria, Dept Econ, E-39005 Santander, Spain
关键词
Pharmaceutical expenditures; business cycles; health care system; H51; I1; I18;
D O I
10.1080/13504851.2015.1102834
中图分类号
F [经济];
学科分类号
02 ;
摘要
Recent research is focused on the study of health care expenditure and fiscal sustainability. In order to facilitate the understanding of this issue, we centre our interest on the Spanish pharmaceutical expenditure. Specifically, using data for the period 1995-2012, in the article we analyse if economic cycles affect pharmaceutical expenditures. Our results support that there is a positive relationship between pharmaceutical expenditure and economic development. Therefore, we conclude that pharmaceutical expenditures are pro cyclical over the last years.
引用
收藏
页码:705 / 707
页数:3
相关论文
共 50 条
  • [2] The Effect of Business Cycles on Health Expenditure: A Story of Income Inequality in China
    Pu, Xiaohong
    Zeng, Ming
    Luo, Yaling
    FRONTIERS IN PUBLIC HEALTH, 2021, 9
  • [3] Pharmaceutical expenditure in Sweden
    Henriksson, F
    Hjortsberg, C
    Rehnberg, C
    HEALTH POLICY, 1999, 47 (02) : 125 - 144
  • [4] FEDERAL RECEIPTS AND EXPENDITURE DURING BUSINESS CYCLES, 1879-1958 - FIRESTONE,JM
    TURVEY, R
    ECONOMICA, 1961, 28 (111) : 337 - 338
  • [5] The impact of Medicare part D on income-related inequality in pharmaceutical expenditure
    Carvalho, Natalie
    Petrie, Dennis
    Chen, Linkun
    Salomon, Joshua A.
    Clarke, Philip
    INTERNATIONAL JOURNAL FOR EQUITY IN HEALTH, 2019, 18 (1)
  • [6] The impact of Medicare part D on income-related inequality in pharmaceutical expenditure
    Natalie Carvalho
    Dennis Petrie
    Linkun Chen
    Joshua A. Salomon
    Philip Clarke
    International Journal for Equity in Health, 18
  • [7] RESEARCH EXPENDITURE IN PHARMACEUTICAL INDUSTRY
    不详
    NATURE, 1964, 202 (492) : 140 - &
  • [8] EU PHARMACEUTICAL EXPENDITURE FORECAST
    Remuzat, C.
    Toumi, M.
    Vataire, A. L.
    Cetinsoy, L.
    VALUE IN HEALTH, 2013, 16 (03) : A254 - A255
  • [9] Pharmaceutical expenditure - a burning issue
    Groendal, Gerdur
    Bjoernsson, Einar S.
    LAEKNABLADID, 2013, 99 (05): : 233 - 233
  • [10] THE SUSTAINABILITY OF IRISH PHARMACEUTICAL EXPENDITURE
    Walshe, V
    Kenneally, M.
    VALUE IN HEALTH, 2013, 16 (07) : A469 - A469